Krsnaa Diagnostics IPO
Krsnaa Diagnostics IPO — date, price band, lot size & details 2021
Krsnaa Diagnostics listed on 16 Aug 2021 at ₹1,005.55, 5.4% above the ₹954 issue price.
Krsnaa Diagnostics provides imaging, pathology and tele-radiology services, much of it through public private partnerships with government hospitals. Its total income was Rs 661.48 crore in FY2021.
Stock price
Krsnaa Diagnostics is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 14 November.
- Open 04 Aug 2021
- Close 06 Aug 2021
- Allotment 11 Aug 2021
- Refund/credit 12 Aug 2021
- Listing 16 Aug 2021
Issue summary
The terms of the offer, as filed.
| IPO Dates | 4 to 6 Aug, 2021 |
|---|---|
| Price Band | ₹933 – ₹954 |
| Face Value | ₹5 |
| Lot Size | 15 Shares |
| Issue Size | ₹1213.33 Cr |
| Sale Type | Fresh capital cum OFS |
| Listing On | BSE, NSE |
| Employee Discount | Rs 93.00 per share |
| Registrar | KFin Technologies Limited |
| Min Investment | ₹ 14,310 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 15 shares at the ₹954 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 15 | ₹14,310 |
| Retail (max) | 13 | 195 | ₹1,86,030 |
| S-HNI (min) | 14 | 210 | ₹2,00,340 |
| S-HNI (max) | 69 | 1,035 | ₹9,87,390 |
| B-HNI (min) | 70 | 1,050 | ₹10,01,700 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 6
- 01Total income rose from Rs 214.32 crore in FY2019 to Rs 661.48 crore in FY2021.
- 02The company turned from a loss of Rs 111.95 crore in FY2020 to a profit of Rs 184.93 crore in FY2021.
- 03EBITDA was Rs 358.83 crore in FY2021.
- 04The pre-issue P/E was 14.03 at the upper band of Rs 954, based on EPS of Rs 68.01.
- 05It ran 1,801 diagnostic centres on 31 December 2020 and has served more than 23 million patients since inception.
- 06Rs 400.84 crore of the issue was fresh capital for new centres and debt repayment.
Risks · 6
- 01Much of the business comes from public private partnership contracts, so tender wins, renewals and payments by government bodies drive results across its 1,801 centres.
- 02The company made losses of Rs 58.06 crore in FY2019 and Rs 111.95 crore in FY2020 before the FY2021 profit.
- 03Net worth was negative at minus Rs 196.98 crore on 31 March 2020.
- 04Rs 812.49 crore of the Rs 1,213.33 crore issue was offer for sale, so most of the money went to selling investors.
- 05Total borrowing was Rs 231.78 crore on 31 March 2021, almost equal to net worth of Rs 231.87 crore.
- 06Promoters and the promoter group held only 31.62% before the issue and 27.38% after it.
Three years of numbers
All figures in ₹ crore, as reported in the Krsnaa Diagnostics offer document.
| Metric | 31 Mar 2021 | 31 Mar 2020 | 31 Mar 2019 |
|---|---|---|---|
| Assets | 604.53 | 629.98 | 528.99 |
| Total Income | 661.48 | 271.38 | 214.32 |
| Profit After Tax | 184.93 | -111.95 | -58.06 |
| EBITDA | 358.83 | -101.26 | -32.52 |
| NET Worth | 231.87 | -196.98 | -84.92 |
| Reserves and Surplus | -17.02 | -217.16 | -105.11 |
| Total Borrowing | 231.78 | 231.25 | 169.21 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Krsnaa Diagnostics RHP. EPS and P/E are post-issue — the table below carries the pre-issue comparison.
Krsnaa Diagnostics IPO Valuation
How the issue prices the company before and after the fresh shares are created.
| Valuation Metric | Pre-Issue | Post-Issue |
|---|---|---|
| EPS (₹) | ₹68.01 | ₹58.90 |
| P/E Ratio (x) | 14.03 | 16.20 |
| Market Cap at Offer Price (₹ Cr) | ₹2,594.08 | ₹2,995.30 |
Pre-issue figures use the shareholding reported in the RHP; post-issue figures use the shareholding once the fresh issue has created new shares. The two differ because of that dilution and because post-issue earnings per share are often annualised, so the change can run in either direction. Market capitalisation is calculated at the ₹954 offer price. Compare the post-issue P/E against listed peers before deciding — a premium there is growth you are paying for in advance.
Where the money goes
₹378.63 Cr of the issue is earmarked to named objects.
Krsnaa Diagnostics IPO Anchor Investors
44 anchor investors across 21 fund houses committed ₹536.98 Cr a day before the issue opened.
Anchor investors bid a day before the issue opens and are locked in after allotment, so a book weighted towards domestic mutual funds is generally read as a stronger signal than one filled by short-horizon funds. Browse every anchor investor scheme or fund house we track.
About the company
It focuses on the public private partnership diagnostics segment and on non-metro and smaller cities. It runs one of India's largest tele-radiology reporting hubs in Pune, which reads X-rays, CT scans and MRI scans round the clock.
On 31 December 2020 it ran 1,801 diagnostic centres, with a footprint in 13 states. It has served more than 23 million patients since inception, including 5.27 million patients in fiscal 2020.
The IPO was Rs 1,213.33 crore, with Rs 400.84 crore of fresh issue and Rs 812.49 crore of offer for sale by investors Phi Capital, Kitara and Somerset. Rs 150.81 crore was planned for new diagnostic centres and Rs 146.08 crore for repaying borrowings.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
The bankers & the filings
Who is running the book, and the documents this page is built from.
Krsnaa Diagnostics IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
JM Financial Ltd.
172 issues handledBest listing: Tata Technologies (+140.0%). Weakest: ACME Solar Holdings (-13.1%).
Equirus Capital Pvt.Ltd.
36 issues handledBest listing: G R Infraprojects (+105.0%). Weakest: Metro Brands (-12.6%).
IIFL Capital Services Limited
146 issues handledBest listing: Unicommerce eSolutions (+117.6%). Weakest: ICICI Securities (-16.3%).
Dam Capital Advisors Ltd
70 issues handledBest listing: Go Colors (+89.9%). Weakest: Metro Brands (-12.6%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Krsnaa Diagnostics?
The current Grey Market Premium is ₹0.
What is the Krsnaa Diagnostics IPO price band?
₹933 to ₹954, on a face value of ₹5.
When is the allotment?
The basis of allotment is 11 August 2021, with listing on 16 August 2021.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — KFin Technologies Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
